Gain Therapeutics, a clinical-stage biotech company, announced that CEO Gene Mack will participate in a virtual fireside chat at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit on June 15, 2026. The company is developing GT-02287, a drug candidate in Phase 1b trials for Parkinson's disease and other neurodegenerative disorders. This event provides Gain an opportunity to update investors and experts on its progress and future plans. The company also has multiple preclinical assets targeting rare diseases and cancers, leveraging its Magellan™ platform for drug discovery.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Frasers Group PLC has withheld financial guidance for the upcoming year due to uncertainty around its takeover bids for Hugo Boss and Accent Group. The retailer's full-year adjusted profit before tax fell 4% to £538 million, impacted by asset impairm...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
